A new facility in Beloit will help Wisconsin increase domestic supply of a critical isotope for the health care industry.

NorthStar Medical Radioisotopes recently finished construction and equipment installation at a new facility in Beloit to produce the medical radioisotope molybdenum-99. NorthStar will produce the isotope without using highly enriched uranium, reducing global nuclear proliferation risks.

Max Postman, program manager for the domestic Molybdenum-99 Program within the U.S. Department of Energy’s National Nuclear Security Administration, said the isotope is used in 40,000 diagnostic medical procedures each day.

Click here to read the full article.